Melinda Wong

491 citations
14 papers · 340 indexed · h-index 8
Topics
Systemic Lupus Erythematosus Research (4 papers)Atherosclerosis and Cardiovascular Diseases (3 papers)Blood properties and coagulation (2 papers)

In The Last Decade

Melinda Wong

12 papers receiving 330 citations

Peers

Melinda Wong
Comparison fields: 5 of 67
  • Rheumatology 171
  • Cardiology and Cardiovascular Medicine 110
  • Immunology 70
  • Surgery 45
  • Pulmonary and Respiratory Medicine 41
Replace Jieyu He with:
Jieyu He China
Grunde Wibetoe Norway
Zygmunt Kopczyński Poland
Fotios Κolokathis Greece
Mustafa Demirtürk Türkiye
Chufan Luo China
Shengjue Xiao China
Shiv K. Seth United States
J. Alcedo González United Kingdom
Melinda Wong relative to Jieyu He China Jieyu He's profile →
Citations per field
00.5×1.5×2.3×
Jieyu He · 1×
Citations per year

Countries citing papers authored by Melinda Wong

Since Specialization
Citations

This map shows the geographic impact of Melinda Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda Wong more than expected).

Fields of papers citing papers by Melinda Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melinda Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda Wong. The network helps show where Melinda Wong may publish in the future.

Co-authorship network of co-authors of Melinda Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Melinda Wong. A scholar is included among the top collaborators of Melinda Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melinda Wong. Melinda Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 6
5 18
6 6
7 80
8 18
9 13
10
Cardiovascular issues of COX-2 inhibitors and NSAIDs.
13
11 156
12 1
13 14
14 14

About Melinda Wong

Melinda Wong is a scholar working on Rheumatology, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 14 papers that have together received 340 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (4 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Blood properties and coagulation (2 papers). The work is most often cited by research in Rheumatology (171 citations), Cardiology and Cardiovascular Medicine (110 citations) and Immunology (70 citations). Melinda Wong has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Phil Chowienczyk, B. Jiang, B. W. Kirkham, Alicia J. Jenkins, Connie Karschimkus, Evange Romas, Ian P. Wicks, Geoff McColl, James D. Best and George Dragicevic. Their work appears in journals such as Journal of the American College of Cardiology, PLoS ONE and The American Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026